Importantly, IL4 inhibited AML cells also in vivo, with the most prominent antileukemic effect obtained upon retroviral secretion of IL4 by leukemic cells, as compared with intraperitoneal injections of IL4. The gene discussed is IL4; the disease is acute myeloid leukemia.